Company intelligence / Profile preview

SPL-Changzhou

Changzhou, Jiangsu, China
Ownership
Private
Development stage
Other
01

Overview

SPL (Changzhou) is a specialized manufacturer of animal-derived active pharmaceutical ingredients (APIs), primarily focusing on heparin sodium and pancreatin. Located in Changzhou, China, the company serves as a strategic production hub for its parent organization, Scientific Protein Laboratories (SPL), which is a subsidiary of Shenzhen Hepalink Pharmaceutical Group. The facility is designed to meet international regulatory standards, including US FDA and EU GMP requirements, ensuring a reliable supply of critical biological components for the global healthcare market. SPL (Changzhou) leverages advanced extraction and purification technologies to produce high-purity ingredients used in anticoagulants and digestive health treatments. The company plays a vital role in the global supply chain by maintaining rigorous quality control and traceability for its biological products.

Therapeutic areas
CardiovascularGastroenterology
Modalities
BiologicSmall moleculeProtein
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on SPL-Changzhou.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPL-Changzhou.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call